MEMStim
Private Company
Funding information not available
Overview
Founded in 2016 and based in Minneapolis, MEMStim is a private medical device company that serves as a contract manufacturer and technology partner for the neurostimulation industry. Its core innovation is the automated production of next-generation neural electrode leads using proprietary microfabrication and 3D printing processes, which dramatically increase production scale, reduce device size, and improve performance compared to traditional hand-assembled methods. The company targets applications including hearing loss (cochlear implants), vision loss, chronic pain, heart failure, tremors, and seizures. MEMStim is in an early revenue stage, operating as a business-to-business (B2B) service and platform provider to larger medical device OEMs.
Technology Platform
Proprietary microfabrication and 3D printing platform for the automated manufacturing of high-density, miniaturized, biocompatible electrode leads for implantable neurostimulation devices.
Opportunities
Risk Factors
Competitive Landscape
MEMStim competes against traditional hand-assembly operations within large medtech companies (e.g., Medtronic, Boston Scientific, Cochlear) and other specialized contract manufacturers. Its primary competitive advantage is its focused expertise in microfabrication for neural interfaces, which offers superior scalability, miniaturization, and consistency compared to conventional methods.